banner

Posts tagged as: Rodman and Renshaw back to homepage

Cardium to Present at Rodman and Renshaw Conference Cardium to Present at Rodman and Renshaw Conference(0)

Cardium to Present at the Rodman & Renshaw Annual 2012 Healthcare Investment Conference

Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present at the Rodman & Renshaw Annual Healthcare Investment Conference on Monday, September 10, 2012 at 3:15 p.m. Eastern Time. The conference is being held September 9-11, 2012 at the Waldorf-Astoria Hotel in New York City. An audio webcast of the Company’s presentation will be available live and by replay and can be accessed at Read More

OTCBB News

Genesis Completes Acquisitions of ADEX and TNS Genesis Completes Acquisitions of ADEX and TNS(0)
iMetrik M2M Solutions Heads Towards Full Scale Production and Receives FCC Certification iMetrik M2M Solutions Heads Towards Full Scale Production and Receives FCC Certification(0)
Death of Actor Highlights Need for Portable Emergency Oxygen Death of Actor Highlights Need for Portable Emergency Oxygen(0)
Axion International Shares Climb on New Contract News Axion International Shares Climb on New Contract News(0)
Scio Diamond Hits Milestone with Mosaic Diamond Growth Production Scio Diamond Hits Milestone with Mosaic Diamond Growth Production(0)
Cortex Pharmaceuticals Expands Pipeline through Merger with Pier Pharma Cortex Pharmaceuticals Expands Pipeline through Merger with Pier Pharma(0)
read more


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Gateways

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories
Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.